Abstract
This review deals with the development of peptide-based radiopharmaceuticals for the use with positron emission tomography and peptide receptor radiotherapy. It discusses the pros and cons of this class of radiopharmaceuticals as well as the different labelling strategies, and summarises approaches to optimise metabolic stability. Additionally, it presents different target structures and addresses corresponding tracers, which are already used in clinical routine or are being investigated in clinical trials.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Tree Can Be Recognized by Its Fruit;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024
2. Next generation radiotheranostics promoting precision medicine;Annals of Oncology;2023-06
3. Lutetium-177: Production and Radiopharmaceuticals;Nuclear Medicine Seminars;2023-03-01
4. Peptides as Vectors for Radiopharmaceutical Therapy;Radiopharmaceutical Therapy;2023
5. Introduction: The Case for Radiopharmaceutical Therapy;Radiopharmaceutical Therapy;2023